Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)

3.640 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

April 22, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

April 15, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

April 14, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Earnings Preview: Ironwood Pharmaceuticals ↗

November 06, 2024

Via Benzinga

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug ↗

April 14, 2025

Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior studies.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 14, 2025

Via Benzinga

Crude Oil Moves Lower; M&T Bank Earnings Miss Views ↗

April 14, 2025

Via Benzinga

Topics Earnings

Gapping stocks in Monday's session ↗

April 14, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

These stocks are moving in today's pre-market session ↗

April 14, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Nasdaq Surges 2%; Goldman Sachs Posts Upbeat Earnings ↗

April 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 14, 2025

Via Benzinga

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

April 14, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

March 27, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

February 27, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

February 20, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Let's take a look at the stocks that are in motion in today's session. ↗

January 30, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top stock movements in today's session. ↗

January 30, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

January 30, 2025

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

January 29, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

January 29, 2025

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 26, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

November 13, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

November 07, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

October 28, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

October 24, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

August 29, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗

August 08, 2024

IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

August 08, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

July 25, 2024

From Ironwood Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.